View Post

How 3,500 women helped save my sister’s life

In Clinical Trials by Barbara Jacoby

By: Lindsey Wahlstrom-Edwards Source: antidote.me I have never been one for anniversaries, but life after my sister’s diagnosis with triple positive breast cancer seems to be full of them. December 1st she found a tumor. December 15th we learned it was cancer. December 17th – her 35th birthday – we learned it was HER2+. December 26th – the fourth anniversary …

View Post

Top 5 Myths About Cancer Clinical Trials

In Clinical Trials by Barbara Jacoby

By: Jill Weberding From: medium.com Clinical trials are the only avenue that advances in medicine occur. Every approved drug or treatment must go through the clinical trial process. With the increasing pace of science and technology advances, there were 19 drugs with new approvals for cancer treatment in 2018 according to “CenterWatch” (n.d.). Despite the excitement of tapping into the …

View Post

Proton Radiotherapy Safe, Effective for Nonmetastatic Breast Cancer

In Clinical Trials by Barbara Jacoby

From: oncnet.com Proton radiotherapy is an effective and safe alternative to conventional radiotherapy, according to results from a phase 2 study of patients with nonmetastatic breast cancer (J Clin Oncol. 2019 Aug 26. Epub ahead of print). Rachel Jiminez, MD, Massachusetts General Hospital, Boston, MA, and colleagues, conducted the phase 2 study with aims to evaluate the safety and efficacy of …

View Post

AIM ImmunoTech Announces Progress Toward Opening of Breast Cancer Study at Roswell Park Comprehensive Cancer Center

In Clinical Trials by Barbara Jacoby

Source: ACCESSWIRE From: yahoo.com AIM ImmunoTech Inc., (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases – such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) – announced progress toward the opening of Roswell Park Comprehensive Cancer Center’s Phase 1 clinical study of chemokine modulation plus neoadjuvant chemotherapy in …

View Post

Context Therapeutics and SOLTI launch ONAWA: a Window of Opportunity Study in Breast Cancer with Apristor

In Clinical Trials by Barbara Jacoby

Source: Business Wire From: manchestertimes.com Context Therapeutics, a clinical-stage biopharmaceutical company dedicated to advancing medicines for hormone driven cancers, today announced a clinical collaboration with SOLTI, a leading collaborative and academic group in Spain dedicated to clinical and translational research in breast cancer. This clinical collaboration, being supported by Context and sponsored by SOLTI, is a window of opportunity study …

View Post

New SU2C teams accelerate clinical trials for difficult breast & prostate cancers

In Clinical Trials by Barbara Jacoby

Source: Stand Up To Cancer From: eurekalert.org Stand Up To Cancer (SU2C) is launching teams of experts to lead innovative attacks on two types of cancer that have defied conventional treatment: triple-negative breast cancer (TNBC) in women and metastatic prostate cancer in men. The $6 million effort supported by SU2C Catalyst Founding Collaborator, Genentech, a member of the Roche Group, …

View Post

Startup joins Roche to hold clinical trials for double-whammy cancer drug

In Clinical Trials by Barbara Jacoby

By: Shoshanna Solomon From: imesofisrael.com DSP-107, developed by KAHR Medical, hopes to have dual impact: tag cancer cells, and boost activity of the immune cells that target them KAHR Medical, an Israeli biopharmaceutical company, says it is developing a second generation class of  immunotherapy drugs that it hopes will be more effective in tackling cancer, based on the lessons learned …

View Post

Varian Unveils Innovative New Solution for Adaptive Therapy

In Clinical Trials by Barbara Jacoby

Source: PR Newswire From: yahoo.com Key Highlights – Ethos therapy provides an opportunity to transform cancer care – Represents the first artificial intelligence (AI)-powered personalized cancer care delivery system in radiation oncology* – Utilizes multi-modality images (MR, PET, CT) and daily iterative CBCT imaging to help clinicians assess anatomical changes and adapt the treatment plan while patient is on the …

View Post

Newly Approved Targeted Therapy Paves the Way for Patients With Advanced Bladder Cancer

In Clinical Trials by Barbara Jacoby

By: Katie Kosko From: curetoday.com Patients with advanced bladder cancer and a specific gene mutation have a promising new treatment option, according to phase 2 study findings published in the New England Journal of Medicine. The international trial was led by researchers from The University of Texas MD Anderson Cancer Center and included 99 patients with metastatic urothelial carcinoma or …

View Post

CRISPR may explain why so many experimental cancer drugs fail

In Clinical Trials by Barbara Jacoby

By: Sally Robertson, B.Sc. From: news-medical.net Researchers in the United States have discovered that many experimental cancer drugs may be missing their molecular targets and are instead succeeding in unintended ways, some of which could have toxic effects. Using the gene-editing tool CRISPR–Cas9 to investigate how ten cancer drugs interact with their protein target, the researchers found that the proteins …